ABPI: UK aims high on life sciences, but investment lags behind pharma The government’s newly unveiled Life Sciences Sector Plan lays out an ambition to position the UK as a global life sciences leader by 2030. But the pharmaceutical industry has pushed back, warning that without major reforms to medicine funding and pricing, the strategy risks underdelivering. Published on Wednesday as part of government’s Industrial Strategy, the [...]
Support for innovation is needed in Budget warns pharmaceutical industry pharma The Association of the British Pharmaceutical Industry (ABPI) has called on Rachel Reeves to prioritise research and development (R&D) investment in the coming Labour Budget to unlock the potential of the UK life sciences sector. The APBI’s pre-Budget submission stressed the importance of maintaining and increasing public R&D funding to increase the UK’s attractiveness as [...]